---
title: "Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292193888.md"
description: "Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect"
datetime: "2026-07-09T11:50:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292193888.md)
  - [en](https://longbridge.com/en/news/292193888.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292193888.md)
generator: "portal-rs"
---

# Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect


### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)

## Related News & Research

- [Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares](https://longbridge.com/en/news/296941366.md)
- [BREAKINGVIEWS-AstraZeneca's blocked M&A signals tough CEO finale](https://longbridge.com/en/news/296766497.md)
- [Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene](https://longbridge.com/en/news/296131073.md)
- [China approves J&J's oral psoriasis pill, says drugmaker](https://longbridge.com/en/news/297158718.md)
- [FDA grants accelerated approval to Bristol Myers Squibb’s ZENBEXUS for relapsed multiple myeloma combo use](https://longbridge.com/en/news/295848217.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**